Phase II Trial of Lenalidomide, Cyclophosphamide, and Dexamethasone (CRd) for Newly Diagnosed Myeloma.
Year: 2007
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Shaji Kumar, Suzanne R. Hayman, Francis K. Buadi, Martha Q. Lacy, Keith Stewart, Philip R. Greipp, Stephen Russell, Steven Zeldenrust, Morie A. Gertz, Leif Bergsagel, Rafael Fonseca, Jacob Allred, Megan Campbell, John A. Lust, Thomas E. Witzig, Robert A. Kyle, S. Vincent Rajkumar, Angela Dispenzieri
Institutions: Mayo Clinic, Mayo Clinic in Arizona
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2564397905